サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1352871

ゲノミクスにおける人工知能の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

Global Artificial Intelligence in Genomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 335 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ゲノミクスにおける人工知能の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 335 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノミクスにおける人工知能市場の世界需要は、調査期間2023年～2030年のCAGR33.3%で、2022年の11億3,000万米ドルから2030年にはほぼ112億2,000万米ドルの市場規模に達すると推定されます。

ゲノミクスにおける人工知能は、遺伝子疾患を診断・理解するためのヘルスケア分野における機械学習の活用を含みます。ゲノミクスにおける人工知能は、ヘルスケア専門家が患者のがんやいくつかの希少な変性疾患のような致命的な疾患をより良く理解するのに役立ちます。人工知能はゲノムデータの構造化に役立ち、人間が介入するよりも早く病気を解釈するのに大いに役立ちます。人工知能は、遺伝物質の構造、機能、発達をより迅速に分析することを可能にします。

市場力学：

ゲノミクスにおける人工知能市場は、予測期間中に満足のいく成長率を示します。個別化医療におけるゲノミクスの役割は、人工知能の応用が医薬品の迅速な製造に役立つため、この市場の成長に寄与します。医薬品開発の時間とコストを削減する必要性と、官民機関によるゲノミクスにおける人工知能への投資の増加が、市場の成長に寄与しています。さらに、ヒトの疾患における遺伝、ライフスタイル、環境の役割に焦点を当てた精密医療の製造が拡大していることも、市場成長の促進要因となっています。同様に、薬を処方する前に患者の遺伝子プロファイルを使用して個々の患者の要件を発見する個別化医療法は、ゲノミクスにおける人工知能市場の成長に影響を与える可能性が高いです。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、ゲノミクスにおける人工知能の世界市場における各セグメントを包括的に評価することもできます。ゲノミクスにおける人工知能産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカのゲノミクスにおける人工知能市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ゲノミクスにおける人工知能- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

5 COVID-19発生の影響分析

  • COVID-19発生の影響分析
    • 生産への直接的影響
    • サプライチェーンと市場の混乱
    • 企業および金融市場への財務的影響
  • COVID-19の生産、輸入、輸出、需要による影響分析
  • 市場COVID-19以前／以後
  • コロナウイルス（COVID-19）流行の影響予測
  • COVID-19：ミクロおよびマクロ要因分析

第6章 ゲノミクスにおける人工知能の世界市場分析：オファリング別

  • オファリング別概要
  • 実績データと予測データ
  • オファリング別分析
  • ソフトウェア
  • サービス

第7章 ゲノミクスにおける人工知能の世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 機械学習
  • ディープラーニング
  • 教師あり学習
  • 強化学習
  • 教師なし学習
  • その他の機械学習技術
  • その他の技術

第8章 ゲノミクスにおける人工知能の世界市場分析：機能別

  • 機能別概要
  • 実績データと予測データ
  • 機能別分析
  • ゲノムシーケンス
  • 遺伝子編集
  • 臨床ワークフロー
  • 予測遺伝子検査と予防医学

第9章 ゲノミクスにおける人工知能の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 診断
  • 創薬・医薬品開発
  • 精密医療
  • 農業・動物研究
  • その他のアプリケーション

第10章 ゲノミクスにおける人工知能の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 製薬・バイオテクノロジー企業
  • ヘルスケアプロバイダー
  • 研究センター、学術機関
  • 政府機関
  • その他のエンドユーザー

第11章 ゲノミクスにおける人工知能の世界市場分析：地域別

  • 上位企業シェア分析
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第12章 ゲノミクスにおける人工知能企業の競合情勢

  • ゲノミクスにおける人工知能市場競争
  • パートナーシップ／提携／合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • IBM（米国）
  • Microsoft（米国）
  • NVIDIA Corporation（米国）
  • Deep Genomics（カナダ）
  • Benevolent人工知能（英国）
  • Fabric Genomics Inc.（米国）
  • Verge Genomics（米国）
  • Freenome Holdings Inc.（米国）
  • MolecularMatch Inc.（米国）
  • Cambridge Cancer Genomics（英国）
  • SOPHiA GENETICS（米国）
  • Data4Cure Inc.（米国）
  • PrecisionLife Ltd（英国）
  • Genoox Ltd.（米国）
  • Lifebit（英国）
  • Diploid（ベルギー）
  • FDNA Inc.（米国）
  • DNAnexus Inc.（米国）
  • Empiric Logic（Ireland）
  • Engine Biosciences Pte. Ltd.（米国）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Artificial Intelligence In Genomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Artificial Intelligence In Genomics Report
  • Market Research Process
  • Market Research Methodology
  • Global Artificial Intelligence In Genomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Offering
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Functionality
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by Functionality (USD MN)
  • Genome Sequencing Market Sales by Geography (USD MN)
  • Gene Editing Market Sales by Geography (USD MN)
  • Clinical Workflows Market Sales by Geography (USD MN)
  • Predictive Genetic Testing & Preventive Medicine Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery & Development Market Sales by Geography (USD MN)
  • Precision Medicine Market Sales by Geography (USD MN)
  • Agriculture & Animal Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotech Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Research Centers, Academic Institutes Market Sales by Geography (USD MN)
  • Government Organizations Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218912

The global demand for Artificial Intelligence in Genomics Market is presumed to reach the market size of nearly USD 11.22 BN by 2030 from USD 1.13 BN in 2022 with a CAGR of 33.3% under the study period 2023 - 2030.

Artificial Intelligence in Genomics involves the utilization of machine learning in the field of healthcare to diagnose and understand genetic disorders. AI in genomics helps healthcare professionals to understand better deadly diseases like cancer and several rare and degenerative conditions in patients. AI helps in the structuring of genomic data, and this helps a great deal in interpreting diseases faster than doing it through human intervention. It enables a faster analysis of the structure, functioning and development of the genetic materials.

MARKET DYNAMICS:

Artificial Intelligence in Genomics market shows a satisfactory growth rate during the projection period. The role of genomics in personalized medicine will help the growth of this market as the application of AI helps in the faster manufacturing of medicines. The necessity to reduce time and cost in drug development and increase investments made in AI in genomics by the public and private sector organizations have contributed to the market's growth. Moreover, the growing manufacturing of precision medicine, which focuses on the role of genetics, lifestyle, and environment in the diseases in humans, is another market driver of growth. Similarly, the personalized medicine method that uses patients' genetic profiles to discover the individual patient requirements before prescribing medicine is likely to influence the growth of the AI in genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in genomics. The growth and trends of artificial intelligence in genomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence in genomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Functionality

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Pharmaceutical & Biotech Companies
  • Healthcare Providers
  • Research Centers, Academic Institutes
  • Government Organizations
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence in Genomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in genomics market include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE IN GENOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Offering
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Functionality
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY OFFERING

  • 6.1 Overview by Offering
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Offering
  • 6.4 Software Historic and Forecast Sales by Regions
  • 6.5 Services Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Machine Learning Historic and Forecast Sales by Regions
  • 7.5 Deep Learning Historic and Forecast Sales by Regions
  • 7.6 Supervised Learning Historic and Forecast Sales by Regions
  • 7.7 Reinforcement Learning Historic and Forecast Sales by Regions
  • 7.8 Unsupervised Learning Historic and Forecast Sales by Regions
  • 7.9 Other Machine Learning Technologies Historic and Forecast Sales by Regions
  • 7.10. Other Technologies Historic and Forecast Sales by Regions

8 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY FUNCTIONALITY

  • 8.1 Overview by Functionality
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Functionality
  • 8.4 Genome Sequencing Historic and Forecast Sales by Regions
  • 8.5 Gene Editing Historic and Forecast Sales by Regions
  • 8.6 Clinical Workflows Historic and Forecast Sales by Regions
  • 8.7 Predictive Genetic Testing & Preventive Medicine Historic and Forecast Sales by Regions

9 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Diagnostics Historic and Forecast Sales by Regions
  • 9.5 Drug Discovery & Development Historic and Forecast Sales by Regions
  • 9.6 Precision Medicine Historic and Forecast Sales by Regions
  • 9.7 Agriculture & Animal Research Historic and Forecast Sales by Regions
  • 9.8 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Pharmaceutical & Biotech Companies Historic and Forecast Sales by Regions
  • 10.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 10.6 Research Centers, Academic Institutes Historic and Forecast Sales by Regions
  • 10.7 Government Organizations Historic and Forecast Sales by Regions
  • 10.8 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE IN GENOMICS COMPANIES

  • 12.1. Artificial Intelligence In Genomics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE IN GENOMICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. IBM (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Microsoft (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. NVIDIA Corporation (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Deep Genomics (Canada)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. BenevolentAI (UK)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Fabric Genomics Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Verge Genomics (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Freenome Holdings Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. MolecularMatch Inc. (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cambridge Cancer Genomics (UK)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. SOPHiA GENETICS (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Data4Cure Inc. (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. PrecisionLife Ltd (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. Genoox Ltd. (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. Lifebit (UK)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments
  • 13.18. Diploid (Belgium)
    • 13.18.1. Company Overview
    • 13.18.2. Company Revenue
    • 13.18.3. Products
    • 13.18.4. Recent Developments
  • 13.19. FDNA Inc. (US)
    • 13.19.1. Company Overview
    • 13.19.2. Company Revenue
    • 13.19.3. Products
    • 13.19.4. Recent Developments
  • 13.20. DNAnexus Inc. (US)
    • 13.20.1. Company Overview
    • 13.20.2. Company Revenue
    • 13.20.3. Products
    • 13.20.4. Recent Developments
  • 13.21. Empiric Logic (Ireland)
    • 13.21.1. Company Overview
    • 13.21.2. Company Revenue
    • 13.21.3. Products
    • 13.21.4. Recent Developments
  • 13.22. Engine Biosciences Pte. Ltd. (US)
    • 13.22.1. Company Overview
    • 13.22.2. Company Revenue
    • 13.22.3. Products
    • 13.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies